# Banco BBVA Argentina S.A.: financial statements, quarterly

BBAR · NYSE · CIK 913059 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bbar.md) · [Financials](/companies/bbar/financials.md) · [Filings](/companies/bbar/filings.md) · [Insiders](/companies/bbar/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/bbar/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2016-12-31) | period not labelled (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [137](/filings/0001193125-20-120341.md) | [118](/filings/0001193125-21-117722.md) | [313](/filings/0001193125-22-102916.md) | [625](/filings/0001193125-23-118482.md) | [1,392](/filings/0001193125-24-099078.md) | [2,883](/filings/0001628280-25-016788.md) | [2,009](/filings/0001628280-25-016788.md) | [2,488](/filings/0001628280-25-016788.md) | [2,823](/filings/0001628280-25-016788.md) |
| Total assets | $bn | [286](/filings/0000950103-19-007082.md) | [319](/filings/0000950103-19-007082.md) | [556](/filings/0001193125-20-120341.md) | [618](/filings/0001193125-21-117722.md) | [1,046](/filings/0001193125-22-102916.md) | [2,008](/filings/0001193125-23-118482.md) | [6,078](/filings/0001193125-24-099078.md) | [13,306](/filings/0001628280-25-016788.md) | [14,720](/filings/0001628280-25-016788.md) |
| Total liabilities | $bn | [247](/filings/0000950103-19-007082.md) | [269](/filings/0000950103-19-007082.md) | [486](/filings/0001193125-20-120341.md) | [503](/filings/0001193125-21-117722.md) | [873](/filings/0001193125-22-102916.md) | [1,691](/filings/0001193125-23-118482.md) | [4,953](/filings/0001193125-24-099078.md) | [10,225](/filings/0001628280-25-016788.md) | [12,104](/filings/0001628280-25-016788.md) |
| Shareholders' equity | $bn | [59.3](/filings/0001193125-20-120341.md) | [49.1](/filings/0000950103-19-007082.md) | [70.0](/filings/0001193125-20-120341.md) | [113](/filings/0001193125-21-117722.md) | [170](/filings/0001193125-22-102916.md) | [311](/filings/0001193125-23-118482.md) | [1,109](/filings/0001193125-24-099078.md) | [3,042](/filings/0001628280-25-016788.md) | [2,574](/filings/0001628280-25-016788.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Total assets: ifrs-full:Assets
- Total liabilities: ifrs-full:Liabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 612,710,079 at 2025-12-31, from the cover of the [20-F filed 2026-04-09](/filings/0001628280-26-024441.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.